Heru Expands Wearable Platform with Launch of Dark Adaptation, Establishing Market-Leading AMD Portfolio
Retrieved on:
星期三, 九月 14, 2022
Research, Technology, Medical Devices, Software, Biotechnology, Hardware, General Health, Health, Optical, Science, Dark, Adaptation, Age-Related Eye Disease Study, AR, MD, Prevalence, Visual impairment, Global Burden of Disease Study, Vision, OCT, Compliance, Health, Drusen, Adaptation (eye), Industry, Field line, Severe cognitive impairment, Patient, Consultant, Physician, CEO, Doctor of Philosophy, PMID, Insurance, Research, AMD, Multimedia, University, OD, Disease, Medical imaging, Central Europe
View the full release here: https://www.businesswire.com/news/home/20220914005233/en/
Key Points:
- View the full release here: https://www.businesswire.com/news/home/20220914005233/en/
Heru adds new testing modality, Dark Adaptation, to its one-of-a-kind, wearable vision screening platform. - We are incredibly pleased to announce the release of dark adaptation further advancing our platform and delivering on our commitment to establish a comprehensive wearable AMD portfolio, said Mohamed Abou Shousha, MD, PhD, CEO, and founder of Heru.
- Dark adaptation testing with the Heru platform is something we have been excited about adopting in our practice.
- With Heru, we are better equipped to detect dark adaptation impairment which studies have shown to be an early indicator of AMD.